Quotient Clinical is a provider of outsourced, early stage drug development services to the global pharmaceutical and biotechnology industries.
Headquartered in Nottingham in the UK, Quotient has developed a platform which offers an integrated approach to formulation development, ‘real-time’ drug product manufacturing and clinical testing. Using this platform has been proven to significantly reduce the time and cost of the early stage drug development process.
It was sold to GHO Capital in 2015.
This investment was made by Bridgepoint Development Capital.
To learn more about the company, click here.